| |
rTM (-)
(n=156) |
rTM (+)
(n=115) |
P-value |
| Age, years, median (range) |
44 (7-77) |
47 (16-71) |
0.3988 |
| Sex, Male/Female |
92/64 |
69/46 |
0.8651 |
| Disease |
| AML |
61 |
41 |
0.6959 |
| ALL |
39 |
24 |
0.5290 |
| MDS |
21 |
17 |
0.7883 |
| Other |
35 |
33 |
0.3650 |
| Conditioning regimen including TBI |
| Yes |
102 |
73 |
0.8823 |
| No |
54 |
42 |
- |
| Donor type |
| Related |
52 |
43 |
0.7493 |
| Unrelated |
104 |
72 |
- |
| Stem Cell Source |
| Bone marrow |
79 |
60 |
0.8875 |
| Peripheral blood |
39 |
18 |
0.1292 |
| Umbilical cord blood |
38 |
37 |
0.2868 |
| Complication after HSCTC |
| Known |
113 |
96 |
0.4440 |
| Yes, aGVHD |
75 |
35 |
0.0149* |
| Yes, VOD and/or TMA |
40 |
18 |
0.0424* |
| No |
22 |
45 |
0.0025** |
| Unknown |
43 |
19 |
0.0877 |
| Survival at Day 60 |
| Known |
108 |
89 |
0.5548 |
| Yes |
72 |
61 |
0.5136 |
| No |
36 |
24 |
0.7295 |
| Unknown |
48 |
22 |
0.0940 |
| Quality of life |
| Known |
70 |
59 |
0.5336 |
| Good |
43 |
38 |
0.4756 |
| Not so good |
27 |
21 |
0.8652 |
| Unknown |
41 |
24 |
0.4177 |
|
